Related Experiment Video

Updated: Aug 29, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis

Yukihiro Kaneko1, Katsunori Yanagihara, Yoshitsugu Miyazaki

  • 1Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.

Respiration; International Review of Thoracic Diseases
|December 11, 2003
PubMed
Abstract

Insights

This study investigated MUC5AC mucin production in diffuse panbronchiolitis (DPB). MUC5AC was found in DPB patients, suggesting its role in the disease, and macrolide treatment showed inhibitory effects.

Area of Science:

  • Pulmonary Medicine
  • Mucinology
  • Respiratory Diseases

Background:

  • Diffuse panbronchiolitis (DPB) is characterized by airway hypersecretion, but the specific mucins involved remain uncharacterized.
  • Understanding mucin genetics in DPB is crucial for elucidating disease pathogenesis.

Purpose of the Study:

  • To determine the production of MUC5AC, a key airway mucin core protein, in patients with DPB.
  • To evaluate the impact of macrolide treatment on MUC5AC production in DPB.

Main Methods:

  • Western blot analysis was used to detect MUC5AC in bronchoalveolar lavage fluid.
  • Comparative analysis included patients with DPB, idiopathic pulmonary fibrosis (IPF), sarcoidosis, and healthy controls.

Main Results:

  • MUC5AC was exclusively detected in the bronchoalveolar lavage fluid of DPB patients.
  • A trend towards inhibition of MUC5AC production was observed following macrolide treatment in DPB patients.

Conclusions:

  • Overproduction of MUC5AC is implicated in the pathogenesis of diffuse panbronchiolitis.
  • MUC5AC serves as a potential biomarker and therapeutic target in DPB.

More Related Videos

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...